Previously we have shown decreased Fas-mediated apoptosis in cord blood lymphocyte subsets. In this study, we compared tumor necrosis factor (TNF)-␣-induced apoptosis in T lymphocytes and their subsets between cord blood and peripheral blood from healthy young controls. The expression of TNF receptor I (TNFR-I) was assessed by flow cytometry and quantitative RT-PCR. The expression of adapter molecules TNF receptor-associated death domain (TRADD), Fasassociated death domain (FADD) and TNF-associated factor-2 (TRAF-2) and caspase 3 was analyzed by Western blotting. The activity of caspase 3 and caspase 8 was measured by colorimetric assay. The susceptibility of CD4 + and CD8
Introduction
Apoptosis is an important physiological mechanism to maintain cellular homeostasis and, in the immune system, to eliminate self-reactive lymphocytes. 1, 2 There are several signaling pathways that lead to cell death; the best characterized are FasL/Fas and tumor necrosis factor/tumor necrosis factor receptor (TNF/TNFR) 2 pathways. [3] [4] [5] Tumor necrosis factor-␣ (TNF-␣) is a 17 kDa pleiotropic proinflammatory cytokine that is predominantly produced by activated monocytes/macrophages and mediates a variety of immunological responses, including host resistance to many infections. [6] [7] [8] TNF-␣ mediates its biological effects via two distinct receptors, TNFR-I and TNFR-II; however, TNF-␣-induced apoptosis is predominantly mediated by TNFR-I and not by TNFR-II, because the latter lacks cytoplasmic death domain. 4, 7, [9] [10] [11] The trimerization of TNFR-I, upon ligation with TNF-␣, induces association of TNFR-I death domains (DD), which in turn interact, with the homotypic death domain of the adapter molecule, the TNFR-associated death domain (TRADD). [12] [13] [14] [15] TRADD acts as a platform to recruit and interact with Fas-associated death domain (FADD), which in turn recruits caspase 8, resulting in the activation of caspase 3 and the induction of apoptosis. The immune system of neonates in humans and animals is functionally immature. [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] Neonatal lymphocytes are functionally immature with regard to proliferative response to mitogens and antigens, cytokine production, antibody production, and other effector functions. Neonatal lymphocytes also demonstrate increased susceptibility to tolerance induction and to the immunosuppressive effects of cyclosporin A and glucocorticoids. [28] [29] [30] Furthermore, the majority of neonatal T cells are naïve (CD45RA + ) phenotype. 18, 31, 32 It has been demonstrated that naïve T cells are less susceptible to apoptosis than memory (CD45RO + ) T cells. 33 Recently, age-related changes in T cell apoptosis have been reported. [34] [35] [36] [37] T cell subsets from aged humans are more susceptible to both Fas-and TNFR-I-mediated apoptosis as compared to young subjects. [34] [35] [36] Furthermore, we have shown that cord blood lymphocytes are less susceptible to Fas-mediated apoptosis; 38 however, TNF-␣-mediated apoptosis in cord blood lymphocytes has not been studied. In addition, neonatal mononuclear cells produce significantly less TNF-␣ than peripheral blood mononuclear cells. 39, 40 Therefore, in this study we compared TNF-␣-induced apoptosis between cord blood and peripheral blood lymphocytes. Our data show that decreased TNF-␣-induced apoptosis in cord blood T cell subsets is associated with decreased expression of TNFR-I, TRADD, and caspase 3, and decreased activity of both caspase 8 and caspase 3. The decreased apoptosis in cord blood is independent of cell surface CD3 density and number of blasts generated following activation with anti-CD3.
Results

TNF-␣-induced apoptosis
Mononuclear cells (MNC) from cord blood and peripheral blood activated with anti-CD3 were incubated in the presence or absence of TNF-␣ for 48 h and apoptosis was measured by terminal deoxytidyl transferase dUTP nick end labelling (TUNEL) assay. Figure 1 shows results from 10 cord blood and 10 peripheral blood samples (% mean ± s.d.). A significantly lower (P Ͻ 0.01) proportion of T cell subsets in cord blood underwent TNF-␣-induced apoptosis (CD4 
Expression of TNFR-I
In order to determine whether the decreased TNF-␣-induced apoptosis in cord blood CD4 + and CD8 + T cells was associated with alteration in TNFR-I expression, we examined the expression of TNFR-I both at the protein and mRNA level. For the expression of TNFR-I at the protein level, MNC were stained with monoclonal antibody to TNFR-I and its isotype control and counterstained with anti-CD4 or anti-CD8 monoclonal antibodies and their isotype controls. Five thousand cells were acquired and analyzed by dual color analysis using FACScan. Data from 10 cord blood and 10 peripheral blood samples are shown in Figure 2 . Figure 2a 
and CD8
+ cells were gated, and the percentage of cells undergoing apoptosis was determined using FL1 channel. Mean ± s.d. data (in percent dead cells) from 10 cord blood and 10 peripheral blood samples are shown. of TNFR-I was significantly lower (P Ͻ 0.01) in cord blood T cell subsets (CD4 + 100 ± 20 and CD8 + 100 ± 16) as compared to peripheral blood T cell subsets (CD4 + 144 ± 12 and CD8 + 122 ± 8). In order to determine whether changes in cord blood lymphocytes were regulated at the transcription level, quantitative RT-PCR was performed in triplicate, using specific primers for TNFR-I; primers for ␤-actin were used as internal controls. Data from five cord blood and five peripheral blood samples are expressed as ratio of TNFR-I:␤-actin (mean ± s.d. of O.D.). There was a decreased expression of TNFR-I mRNA in cord blood MNC as compared to peripheral blood MNC (Figure 3a) . A representative gel photograph using 2 g cDNA from three cord blood and three peripheral blood samples is shown in Figure 3b .
Furthermore, to determine whether TNFR-I was differentially expressed in naïve and memory subsets of CD4 
CD45RA
+ T cell subsets in cord blood and peripheral blood. However, significantly increased (P Ͻ 0.05) proportions of CD8 + CD45RO + T cells from cord blood expressed TNFR-I as compared to peripheral blood CD8
Density of CD3 antigen and T cell blasts
To determine whether decreased density of CD3 antigen may be responsible for decreased generation of T cell blasts and decreased apoptosis in cord blood, MNC were stained with FITC-conjugated anti-CD3 moAb and the fluorescence intensity (as a measure of CD3 density) was analyzed on 5000 cells gated for lymphocytes. No significant difference was observed in CD3 levels (MFC#) between cord blood (mean ± s.d.; 589 ± 6.1) and peripheral blood (mean ± s.d.; 570 ± 15.7) T cells. This observation is in contrast to that of Harris et al 41 who reported decreased density of CD3 on cord blood T cells. However, these investigators did not provide data on background staining with isotype control.
Genes and Immunity
To determine the number of blasts generated following anti-CD3 activation, MNC from three cord blood and three peripheral blood samples were stimulated with anti-CD3 for 48 and analyzed for cell size using forward scatter. No significant difference was observed in the proportions of blasts generated between cord blood (mean ± s.d.; 32.4 ± 1.0) and peripheral blood (mean ± s.d.; 39.4 ± 1.0).
Expression of FADD, TRADD and TRAF-2
TNF-␣, upon binding to TNFR-I, results in trimerization of TNFR-I. This induces association of the receptors' death domain (DD) which then recruits adapters TRADD, TNF-associated factor-2 (TRAF-2) and FADD. 4, 13, 14 Therefore, we analyzed the expression of TRADD, FADD, and TRAF-2 (at the basal level and following treatment with TNF-␣) in cord blood and peripheral blood MNC, using Western blotting. Bands were quantitated by laser densitometer and data are expressed as integrated volume in O.D. Data in Table 1 show that there was no significant difference in the constitutive expression of FADD or TRAF-2 between cord blood and peripheral blood lymphocytes; however, in cord blood MNC the constitutive expression of TRADD was significantly decreased (P Ͻ 0.01) as compared to that in peripheral blood MNC. Figure 5a , 5b, and 5c show representative gels for FADD, TRADD, and TRAF-2 respectively. Furthermore, there was no significant change in the expression of any of these adapter molecules following TNF-␣ treatment (data not shown).
Caspase 8 activity
FADD recruits procaspase 8 via interaction with homotypic death effector domains (DED), resulting in the activation of caspase 8 which in turn activates the downstream signaling pathway leading to apoptosis. Therefore, we examined caspase 8 activity in cord blood and peripheral blood lymphocytes at 24 h and 48 h following treatment with TNF-␣, using FLICE/caspase 8 colorimetric assay kit. Figure 6 shows data from four cord blood and four peripheral blood samples. A significantly lower (P Ͻ 0.05) caspase 8 activity was observed in cord blood lymphocytes as compared to peripheral blood lymphocytes.
Expression and activity of caspase 3
Caspase 8 interacts with procaspase 3 and cleaves and activates caspase 3, which in turn cleaves a number of its cytoplasmic and nuclear substrates, including Poly (ADP ribose) polymerase (PARP), resulting in morphological appearance of apoptosis. Therefore, we examined the expression of caspase 3 by Western blotting, using specific antibody. The activity of caspase 3 in MNC from cord blood and peripheral blood was analyzed by colorimetric assay and by Western blotting of cleaved fragments of caspase 3 (p20) and PARP (p85), using specific monoclonal antibodies. A significantly decreased (P Ͻ 0.01) expression of caspase 3 was observed in cord blood MNC (Table 1 ) as compared to expression in peripheral blood MNC. A representative gel from three different samples of cord blood and peripheral blood is shown in Figure 7 . In order to determine whether decreased constitutive expression of caspase 3 in cord blood MNC was Freshly isolated lymphocytes from cord blood and peripheral blood from young subjects were isolated and cell lysates prepared. Western blotting was performed using FADD, TRADD, TRAF-2, or caspase 3 antibodies. Blots were scanned and the mean integrated volumes calculated for blots performed simultaneously. Mean ± s.d. from five cord blood and five peripheral blood samples. associated with changes in caspase 3 activation following TNF-␣ treatment, caspase 3 activity in cord blood and peripheral blood was measured by colorimetric assay, using an ApoAlert kit (Clonetech, Palo Alto, CA, USA), and by cleavage of caspase 3 and its substrate PARP by Western blotting. MNC were activated with anti-CD3 for 48 h, followed by incubation in interleukin 2 (IL-2) containing medium for 4 days, and then cultured in the presence or absence of TNF-␣ for 48 h. For colorimetric assay, samples were analyzed at 24 h and 48 h following treatment with TNF-␣. An increase in caspase 3 activity was observed in both cord blood and peripheral blood MNC 24 h following treatment with TNF-␣ (Figure 8a ). However, the increase in caspase activity over the baseline value was significantly less (P Ͻ 0. cleavage of caspase 3 was observed in cord blood MNC. In contrast, cleavage of caspase 3 was observed in peripheral blood MNC. Figure 8c shows a representative Western blot gel for PARP cleavage. Significantly less cleavage of PARP was observed in cord blood lymphocytes as compared to that in the peripheral blood.
Discussion
In the present study, we have shown that cord blood T cell subsets are less susceptible to undergoing TNF-␣-induced apoptosis than those in the peripheral blood. Decreased apoptosis in cord blood was associated with decreased constitutive expression of TNFR-I, TRADD, and caspase 3, and decreased activity of both caspase 8 and caspase 3. The decreased apoptosis in cord blood T cells was not due to any difference in the density of CD3 expression or number of T cell blast generated following anti-CD3 stimulation. Furthermore, TNF-␣ production (pg/ml) by T cells following anti-CD3 stimulation was significantly (P Ͻ 0.05) lower in cord blood MNC (mean ± s.d.; 597 ± 213) as compared to peripheral blood MNC (mean ± s.d.; 969 ± 265). TNF-␣ exerts biological effects via binding to its two receptors, p55 TNFR-I and p75 TNFR-II that are expressed on a variety of cells, including lymphocytes.
4,7,9-11 TNFR-I contains a cytoplasmic DD and upon ligation with TNF-␣ signals both apoptotic and cell activation pathways.
4,13 TNF-␣ binds to TNFR-I, resulting in its trimerization, which induces association of the receptors' DD. Subsequently, TRADD binds to the clustered TNFR-I DD via homotypic interaction with its DD. TRADD recruits several adapter molecules, including FADD, that initiate activation of apoptosis via recruitment of regulatory caspase (caspase 8), which in turn cleaves and activates effector caspase 3. FADD serves as a common conduit for both Fas-and TNF-␣-induced apoptosis. Previously, we have shown that cord blood lymphocytes are less susceptible to Fas-mediated apoptosis 38 compared to adult peripheral blood lymphocytes.
The overexpression of TNFR-I triggers cell death. 15 In the present study, we have observed decreased proportions of TNFR-I + CD4 + and CD8 + T cells as well as decreased fluorescence intensity (MFC#) of TNFR-I, suggesting a decreased level of TNFR-I in cord blood as compared to that in peripheral blood.
In cord blood, the majority of T cells are naïve (CD45RA + ) phenotype. 18, 31, 32, 41 Therefore, decreased TNFR-I expression in cord blood T cells could be due to a shift towards CD45RA + population. However, we observed no significant difference in the expression of TNFR-I in CD45RA
+ and CD45RO + subsets of CD4 + and CD45RA
+ subsets of CD8 + T cells between cord blood and peripheral blood. A significant increase in TNFR-I expression was, however, observed in cord blood CD8 +
CD45RO
+ T cells as compared to peripheral blood. Therefore, decreased TNF-␣-induced apoptosis in cord blood T cell subsets is not merely due to a shift to CD45RA + T cells. Similarly, we have observed no relationship between a shift of CD45RO + T cells and increased susceptibility to TNF-␣-and Fas-mediated apoptosis in aged humans. 34, 35 TNFR-I upon trimerization recruits adapter molecules TRADD and FADD in the pathway of apoptosis; TRADD also recruits TRAF-2, which is required for the activation of NF-B. 4, 14 Recently, it has been shown that NF-B activation inhibits apoptosis. [42] [43] [44] Therefore, based upon the type of adapter molecules recruited to its death domain, TNFR-I can mediate both apoptotic and activation signals. Although the significance of constitutive levels of adapter molecules is unclear, overexpression of TRADD is associated with increased apoptosis. 45 In the present study, constitutive expression of TRADD was significantly less in cord blood lymphocytes as compared to peripheral blood lymphocytes. Furthermore, we have observed a correlation between increased expression of TRADD and increased susceptibility to TNF-␣-induced apoptosis in aged humans. 35 Therefore, decreased levels of TRADD in cord blood might be responsible for decreased susceptibility of T cells to undergo TNF-␣-induced apoptosis. The role of TRAF-2 in inhibition of apoptosis has been demonstrated in TRAF-2 knock out mice. 46 TRAF-2 deficient mice appear to be normal at birth but become progressively runted and die prematurely. In these mice, thymocytes and other hematopoietic progenitor cells are highly sensitive to TNF-induced cell death and serum TNF levels are elevated. We observed no significant difference in TRAF-2 expression between cord blood and peripheral blood lymphocytes. However, cord blood mononuclear cells have been shown to produce lower amounts of TNF-␣ as compared to peripheral blood mononuclear cells. 39, 40 The role of activation of NF-B in decreased TNF-␣-induced apoptosis in cord blood T cells remains to be examined.
FADD recruits and interacts with procaspase 8, which is autolytically activated to caspase 8; caspase 8 in turn activates caspase 3, resulting in cleavage of its substrates, including PARP. The significance of the relative levels of constitutive expression of caspases in relation to susceptibility to apoptosis is not known. However, we have observed an association between increased constitutive expression of caspase with increased susceptibility of lymphocytes to Fas-mediated and TNF-␣-induced apoptosis in aged humans. 35, 36 Furthermore, cells that lack STAT protein had low levels of caspases and are resistant to TNF-␣-induced apoptosis. 47 Therefore, it appears that constitutive expression of adapter molecules and caspases may influence apoptosis, perhaps via alterations in kinetics of recruitment of adapter molecules and activation of caspases. In the present study, we observed decreased constitutive expression, decreased activity of caspase 3, and decreased activity of caspase 8 in cord blood lymphocytes as compared to peripheral blood lymphocytes.
In summary, cord blood lymphocytes not only produce a lesser amount of TNF (English et al, 39 Weatherstone and Rich, 40 present study), but they are also less susceptible to TNF-␣-induced apoptosis. The decreased susceptibility to TNF-␣-induced apoptosis in cord blood lymphocytes is associated with decreased expression of TNFR-I and certain adapter molecules, and with decreased expression and activity of both initiator and effector caspases. TNF/TNFR and Fas/FasL pathways are involved in cytotoxic responses. [1] [2] [3] [4] [5] [6] Therefore, a deficiency of these pathways may, in part, be responsible for increased frequency of certain infections observed in neonates. 48 
Materials and methods
Subjects
Cord blood was obtained during normal deliveries. Peripheral blood was obtained from healthy young volunteers (age 20-29 years). The protocol was approved by the Institutional Review Board, University of California, Irvine, CA, USA.
Antibodies
Monoclonal antibody against TNFR-I was purchased from Caltag Inc (South San Francisco, CA, USA). Monoclonal antibodies against CD3, CD4, CD8, CD45RA, CD45RO, and isotype controls were obtained from Becton Dickinson (Mountain View, CA, USA). Monoclonal antibodies to FADD, TRADD, TRAF-2, PARP, caspase 3 and HRP-conjugated goat anti-mouse antibodies were obtained from Transductional Laboratories (Lexington, KY, USA). Anti-CD3 monoclonal antibody (OKT3) was purchased from Ortho Diagnostics (Raritan, NJ, USA).
Cell culture MNC were isolated from cord blood and peripheral blood on Ficoll-Hypaque density gradient. MNC (2 × 10 6 cells/ml) were activated with anti-CD3 monoclonal antibody (25 ng/ml) for 48 h followed by culture in 10 ng/ml of IL-2 (R & D System, Indianapolis, IN, USA) containing medium for 4 days. Cells were then washed with Dulbecco's phosphate buffered saline (DPBS) and incubated further for 48 h in the presence or absence of TNF-␣ (1 g/ml). MNC were analyzed at the beginning and at the end of cultures with monoclonal antibodies against CD3, CD19, and CD14, using FACScan (Becton Dickinson, Palo Alto, CA, USA). At the beginning of cultures, MNC contained 88-92% CD3 + T cells, 5-7% CD20 + B cells, and 4-8% CD14 + monocytes; however, at the end of cultures, MNC contained Ͼ97% CD3 + T cells and Ͻ2% monocytes.
Flow cytometry
TNFR-I expression on T cell subsets was examined with dual or triple color flow cytometry, using FACScan (Becton Dickinson, Mountain View, CA, USA). MNC (1 × 10 6 ) were harvested, washed twice in PBS and resuspended in 0.01 m sodium citrate buffer (pH 4.0) at 4°C for 5 min to remove excess TNF bound to receptors. Cells were washed again in PBS and resuspended in ice-cold wash buffer (PBS, 5% heat-inactivated fetal bovine serum, 0.02% NaN 3 ). All subsequent incubations were done at 4°C. Cells were incubated with anti-TNFR-I monoclonal antibody (1 g/ml) or isotype matched control antibody for 30 min, washed twice in PBS, and then incubated with 1:100 dilution of PE-conjugated goat anti-mouse IgG (5 g/ml). Cells were washed again in PBS and counterstained with fluorescein isothiocyanate (FITC)-labeled anti-CD4 or anti-CD8 monoclonal antibodies for another 30 min on ice. Cells were re-washed in PBS, fixed with 1% paraformaldehyde and analyzed using a FACScan. Results are expressed both as percent TNFR-I positive T cell subsets and as mean fluorescence channel numbers (MFC#). To determine the expression of TNFR-I on CD45RA
+ and CD45RO + subsets of both CD4 + and CD8 + T cells, a triple color analysis was performed. MNC were incubated with FITC-conjugated anti-TNFR-I monoclonal antibody, Per-CP conjugated anti-CD4 or anti-CD8, and PE-conjugated anti-CD45RA anti-CD45RO monoclonal antibodies. FITC-labeled, Per-CP-labeled, and PE-labeled mouse IgG were used as isotype-matched background controls. Cells were washed with PBS, and 5000 cells were acquired using FACScan. Triple color analysis was performed using FACScan Research software (Becton Dickinson, San Jose, CA, USA). Data were expressed as percent of CD45RA + and CD45RO + subsets that were TNFR-I + .
Genes and Immunity
To determine whether the changes in apoptosis in cord blood T cells might be due to a difference in the levels of CD3 on the surface of T cells, 1 × 10 6 cells from cord and peripheral blood were incubated with FITC-labeled anti-CD3 monoclonal antibody or isotype control for 30 min at room temperature. Cells were washed with PBS, resuspended in PBS, and analyzed by FACS. Forward and side angles scatters were used to gate and exclude cellular debris. Cells were excited at 488 nm and green fluorescence was collected on FL1 channel at 530 nm. Density of CD3 molecules as represented by mean fluorescence channel numbers (MFC#, fluorescence intensity) was analyzed using Consort 30 software program of FACScan (Becton Dickinson, San Jose, CA, USA).
TUNEL assay TNF-␣-induced apoptosis was performed using TUNEL assay. Freshly isolated MNC (1 × 10 6 cells/ml) were incubated with PE-labeled anti-CD4 or anti-CD8 antibodies and their isotype controls for 30 min on ice. Cells were washed with DPBS containing 1% bovine serum albumin and 0.1% NaN 3 and fixed in 4% paraformaldehyde for 30 min at room temperature. Cells were washed with DPBS and permeabilized with sodium citrate buffer containing TritonX-100 for 2 min on ice. After washing, cells were incubated with FITC-conjugated dUTP in the presence of TdT enzyme solution containing 1 m potassium cacodylate and 125 mm Tris-Hcl, pH 6.6 (In Situ Death Detection kit, Boehringer Mannheim, Indianapolis, IN, USA) for 1 h at 37°C. Following incubation, cells were washed with DPBS and 5000 cells were acquired and analyzed by dual color flow cytometry, using FACScan.
Western blotting
The expression of FADD, TRADD, and caspase 3, and cleavage of poly (ADP-ribose) polymerase (PARP), were determined by Western blotting. Cells were lysed in a buffer containing 142.5 mm KCl, 5 mm MgCl 2 , 10 mm HEPES (pH7.2), 1 mm EGTA, 0.2% Nonidet P-40, 0.2 mm PMSF, 0.2 trypsin inhibitory U/ml aprotinin, 0.7 g/ml pepstatin, and 1 g/ml leupeptin. Cells were homogenized and centrifuged at 1000 rpm for 8 min. The supernatants were centrifuged at 30 000 g for 45 min to precipitate membrane fractions. Twenty micrograms of cellular protein were loaded onto 4-20% Tris-glycine gel and electrophoresed. The blots were transferred onto nitrocellulose membrane and incubated with primary antibody for 3 h at room temperature in Tris-buffered saline containing 3% skim milk and 0.1% Tween-20 (TBS-MT). The blots were washed thrice in TNS-MT and incubated with HRP-conjugated secondary antibody for another hour in TBS-MT. The blots were washed as before and developed using the enhanced chemiluminescence detection method. The blots were scanned (QuantiScan, Molecular Devices, Sunnyvale, CA, USA) and data were expressed as O.D. of the integrated volume (× 10 3 ).
Quantitative PCR
Total cellular RNA was extracted from unstimulated MNC from both cord blood and peripheral blood samples. cDNA was synthesized using 200 ng of total cellular RNA and 100 ng of random hexamers in a 20 l volume of a solution containing 50 mm tris HCl, 75 mm KCl, 3 mm MgCl 2 , 10 mm DTT, 500 m each of dNTPs and 10 U reverse transcriptase using a RT-PCR kit (Perkin-Elmer, Branchburg, CT, USA). For quantitation, graded amounts of cDNA were used and PCR was carried out as described 41 for 25 cycles. Sense and antisense primers for TNFR-I were purchased from Clontech (Palo Alto, CA, USA). The sequences were as follows: TNFR-I, sense, 5Ј-ATT TGC TGT ACC AAG TGC CAC AAA GGA ACC-3Ј, and antisense, 5Ј-GTC GAT TTC CCA CAA ACA ATG GAG TAG AGC-3Ј. ␤-actin primers were synthesized by Chemgene (Waltham, MA, USA) and used as internal controls. Results are expressed in O.D. ratio for TNFR-I:␤ actin.
Caspase 8 activity
Caspase 8 activity was measured using a FLICE/caspase 8 colorimetric assay kit (BioVision, Palo Alto, CA, USA) according to the manufacturer's instructions. The assay is based on spectrophotometric detection of the chromophore p-nitroanilide (pNA) after its cleavage from the labeled substrate IETD-pNA. In brief, cells were activated as described for caspase 3.1 × 10 6 cells were suspended in lysis buffer and cell lysates were incubated with or without substrate IETD-pNA in the presence of reaction buffer for 1 h at 37°C. The light emission was quantified using a microtiter plate reader at 405 nm. The background (cell lysates incubated without IETD-pNA) was subtracted from cell lysates incubated with the substrate, and relative absorbance was plotted.
Capase 3 activity
Capase 3 activity was measured by colorometric assay using an ApoAlert ™ CPP32 Assay kit (Clontech) and by Western blotting of cleavage fragment (p20) of caspase 3 and of its substrate, poly (ADP-ribose) polymerase (PARP). Briefly, MNC (2 × 10 6 cells/ml) were incubated with anti-CD3 monoclonal antibody (25 ng/ml) for 48 h followed by culture in IL-2 (10 ng/ml) containing medium for 4 days. Cells were washed and incubated in the absence or presence of TNF-␣ for 0, 24, and 48 h. Cells were resuspended in lysing buffer and incubated on ice for 10 min. Following incubation, conjugated protease substrate DEVD-pNA (1 mm) was added to the cell mixture and incubated for another one hour at 37°C. The samples were read by spectrophotometer at 405 nm. Caspase 3 and PARP cleavage were assayed 24 h following anti-TNF-␣ treatment by Western blot using monoclonal anti-PARP antibody against cleaved fragments.
Statistical analysis was performed by paired Student's t-test.
